cs.CVNov 8, 2026

Auto-GlaKG: Automated Biomarker Reasoning for Explainable Glaucoma Detection

Authors: Cheng Huang, Zeyu Han, Yian Hu, Yaopeng Ding, Jingxi Qiu, Yadi Liu

Organizations: Department of Genetics, Washington University in St. Louis, St. Louis, MO 63110, USA · Department of Computer Science, Southern Methodist University, Dallas, TX 75205, USA · Department of Health Data Science and Artificial Intelligence, University of Texas Health Science Center at Houston, Houston, TX 77030, USA · Houston Methodist Neal Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA · 

Abstract

Interpretable glaucoma detection requires a transparent connection between fundus images, clinically meaningful biomarkers, and diagnostic predictions. Knowledge graph (KG) reasoning provides this structure, but performance measured using annotated biomarkers does not establish performance when only images are available. We present Auto-GlaKG, an automated framework that combines image-based biomarker prediction with fixed clinical-prior rules. A ResNet50 network predicts the cup-to-disc ratio (CDR) and six morphological signs using biomarker supervision, and a KG reasoner aggregates their signed rule contributions into a glaucoma score. On 689 fundus images evaluated using stratified, group-aware five-fold cross-validation, Auto-GlaKG achieves a pooled area under the receiver operating characteristic curve (AUC) of 0.951 (95% confidence interval: 0.931--0.969), with sensitivity of 0.970 and specificity of 0.779. The matched image classifier also achieves an AUC of 0.951, while the rule stage adds 0.2~ms per image. Replacing predicted CDR with its annotation increases fold-mean AUC from 0.953 to 0.995. The framework provides an explicit rule-level account of image-based predictions and identifies CDR estimation as a priority for validation using independently measured biomarkers.

Figures & tables

Explore similar work

Jul 6, 2026

GlaKG: A Biomarker-Centric Fundus Knowledge Graph for Explainable Glaucoma Diagnosis and Risk Assessment

Glaucoma is a leading cause of irreversible blindness worldwide, yet most automated diagnosis systems rely on opaque deep-learning models that offer little clinical interpretability. We present GlaKG, a biomarker-centric fundus knowledge graph that integrates structural biomarkers, clinically grounded rules, and image features to produce traceable reasoning for glaucoma diagnosis and risk stratification. GlaKG encodes six entity types (Fundus Image, Optic Disc, Neural Rim, Pathology, Diagnosis, Risk Level), eight relation types, and 11 clinically validated rules into a unified graph, so that every prediction is accompanied by an explicit reasoning chain linking biomarker evidence to activated clinical rules. To keep knowledge-based reasoning strictly separate from label information, we adopt a post-processing fusion framework that combines ResNet50 image embeddings with a normalized KG reasoning-chain score via a tunable weight alpha, with all fitting confined to the training split. On a publicly available, AI-annotated fundus dataset, GlaKG reaches F1 = 0.9953 for binary glaucoma classification and 0.930 accuracy with 0.922 weighted F1 for four-class risk stratification; we report openly that the dataset's biomarker annotations are highly label-correlated, and therefore frame these figures as an upper bound attainable with clean structured biomarkers rather than as leakage-free image-only performance. Feature-importance analysis shows KG-derived and biomarker features contributing near-equally (51.1% vs. 48.9%), and the reasoning chain flags borderline cases by exposing low chain scores rather than failing silently. GlaKG's central contribution is therefore a clinically auditable reasoning framework that complements raw predictive performance by explicitly exposing the biomarker evidence and rule activations behind each decision.
Aug 3, 2025

GlaBoost: A Multimodal Structured Framework for Glaucoma Risk Stratification

Early and accurate glaucoma detection is critical to prevent irreversible vision loss, yet existing AI methods often rely on unimodal inputs and lack interpretability. We present GlaBoost, a multimodal gradient boosting framework that unifies three complementary signals for glaucoma risk prediction: fundus image embeddings from a pretrained convolutional encoder,free-text neuroretinal rim assessments encoded by a transformer-based language model, and structured ophthalmic biomarkers. These modalities are fused into a single representation and classified by an enhanced XGBoost model.On two real-world annotated datasets, GlaBoost consistently outperforms unimodal and generic multimodal baselines. Feature importance analysis highlights the cup-to-disc ratio, rim thinning, and the ISNT rule as the dominant predictors, yielding clinically consistent and interpretable decisions. GlaBoost offers a transparent and scalable foundation for multimodal decision support in ophthalmology.
Apr 14, 2026

Fundus Image-based Glaucoma Screening via Retinal Knowledge-Oriented Dynamic Multi-Level Feature Integration

While deep learning has advanced automated glaucoma screening via color fundus photography, existing purely data-driven models often overfit to confounding imaging artifacts and struggle to capture unpredictable pathological cues located beyond predefined anatomical boundaries. To address these limitations, we propose a retinal knowledge-oriented framework that synergizes dynamic multi-scale feature learning with domain-specific anatomical priors. The proposed architecture adopts a tri-branch structure to jointly model the global retinal context, the structural characteristics of the optic cup and disc, and dynamically cropped pathological regions. Specifically, we devise a Dynamic Window Mechanism (DWM) that adaptively discovers diagnostically informative patches via image-level supervision. Furthermore, we introduce a Knowledge-Enhanced Convolutional Block Attention Module (KE-CBAM) that explicitly incorporates retinal priors from a pre-trained foundation model RETFound to guide spatial attention, preventing the network from assigning spurious weights to irrelevant background noise. Extensive evaluations on the large-scale AIROGS dataset demonstrate that our method achieves a state-of-the-art AUC of 98.5%98.5\% and an accuracy of 94.6%94.6\%. More importantly, the integration of anatomical priors effectively mitigates the inherent class imbalance, significantly improving the detection of referable glaucoma cases. Additional validations on the SMDG-19 benchmark further confirm its superior cross-domain generalization, indicating that our contribution provides a robust, interpretable, and scalable solution for real-world clinical glaucoma diagnosis. Our code is available at https://github.com/magiczhuo/Glaucoma-Detection